Skip to main content
Erschienen in: Diabetologia 5/2018

26.02.2018 | Article

Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index

verfasst von: Andrea Tura, Gaetano Chemello, Julia Szendroedi, Christian Göbl, Kristine Færch, Jana Vrbíková, Giovanni Pacini, Ele Ferrannini, Michael Roden

Erschienen in: Diabetologia | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The euglycaemic–hyperinsulinaemic clamp is the gold-standard method for measuring insulin sensitivity, but is less suitable for large clinical trials. Thus, several indices have been developed for evaluating insulin sensitivity from the oral glucose tolerance test (OGTT). However, most of them yield values different from those obtained by the clamp method. The aim of this study was to develop a new index to predict clamp-derived insulin sensitivity (M value) from the OGTT-derived oral glucose insulin sensitivity index (OGIS).

Methods

We analysed datasets of people that underwent both a clamp and an OGTT or meal test, thereby allowing calculation of both the M value and OGIS. The population was divided into a training and a validation cohort (n = 359 and n = 154, respectively). After a stepwise selection approach, the best model for M value prediction was applied to the validation cohort. This cohort was also divided into subgroups according to glucose tolerance, obesity category and age.

Results

The new index, called PREDIcted M (PREDIM), was based on OGIS, BMI, 2 h glucose during OGTT and fasting insulin. Bland–Altman analysis revealed a good relationship between the M value and PREDIM in the validation dataset (only 9 of 154 observations outside limits of agreement). Also, no significant differences were found between the M value and PREDIM (equivalence test: p < 0.0063). Subgroup stratification showed that measured M value and PREDIM have a similar ability to detect intergroup differences (p < 0.02, both M value and PREDIM).

Conclusions/interpretation

The new index PREDIM provides excellent prediction of M values from OGTT or meal data, thereby allowing comparison of insulin sensitivity between studies using different tests.
Literatur
1.
Zurück zum Zitat DeFronzo RA (2009) Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes. Diabetes 58:773–795CrossRefPubMedPubMedCentral DeFronzo RA (2009) Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes. Diabetes 58:773–795CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Szendroedi J, Phielix E, Roden M (2011) The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 13:92–103 Szendroedi J, Phielix E, Roden M (2011) The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 13:92–103
3.
Zurück zum Zitat Ferrannini E (2006) Is insulin resistance the cause of the metabolic syndrome? Ann Med 38:42–51CrossRefPubMed Ferrannini E (2006) Is insulin resistance the cause of the metabolic syndrome? Ann Med 38:42–51CrossRefPubMed
4.
Zurück zum Zitat DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Phys 237:E214–E223 DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Phys 237:E214–E223
5.
Zurück zum Zitat Tura A, Sbrignadello S, Succurro E, Groop L, Sesti G, Pacini G (2010) An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics. Diabetologia 53:144–152 Erratum in Diabetologia 2010;53:1245CrossRefPubMed Tura A, Sbrignadello S, Succurro E, Groop L, Sesti G, Pacini G (2010) An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics. Diabetologia 53:144–152 Erratum in Diabetologia 2010;53:1245CrossRefPubMed
6.
Zurück zum Zitat Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta cell function. Best Pract Res Clin Endocrinol Metab 17:305–322CrossRefPubMed Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta cell function. Best Pract Res Clin Endocrinol Metab 17:305–322CrossRefPubMed
7.
Zurück zum Zitat Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548CrossRefPubMed Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548CrossRefPubMed
8.
Zurück zum Zitat Mari A, Pacini G, Brazzale AR, Ahrén B (2005) Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test. Diabetologia 48:748–751CrossRefPubMed Mari A, Pacini G, Brazzale AR, Ahrén B (2005) Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test. Diabetologia 48:748–751CrossRefPubMed
9.
Zurück zum Zitat Szendroedi J, Yoshimura T, Phielix E et al (2014) Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci U S A 111:9597–9602CrossRefPubMedPubMedCentral Szendroedi J, Yoshimura T, Phielix E et al (2014) Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci U S A 111:9597–9602CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Szendroedi J, Kaul K, Kloock L et al (2014) Lower fasting muscle mitochondrial activity relates to hepatic steatosis in humans. Diabetes Care 37:468–474CrossRefPubMed Szendroedi J, Kaul K, Kloock L et al (2014) Lower fasting muscle mitochondrial activity relates to hepatic steatosis in humans. Diabetes Care 37:468–474CrossRefPubMed
11.
Zurück zum Zitat Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K (2008) Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51:853–861CrossRefPubMed Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K (2008) Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51:853–861CrossRefPubMed
12.
Zurück zum Zitat Bradnova O, Kyrou I, Hainer V et al (2014) Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones. Obes Surg 24:718–726CrossRefPubMed Bradnova O, Kyrou I, Hainer V et al (2014) Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones. Obes Surg 24:718–726CrossRefPubMed
13.
Zurück zum Zitat Vrbíková J, Cibula D, Dvoráková K et al (2004) Insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:2942–2945CrossRefPubMed Vrbíková J, Cibula D, Dvoráková K et al (2004) Insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:2942–2945CrossRefPubMed
14.
Zurück zum Zitat Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA (2005) β-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90:493–500CrossRefPubMed Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA (2005) β-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90:493–500CrossRefPubMed
15.
Zurück zum Zitat Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E (2005) Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide. Diabetes Care 28:1132–1138CrossRefPubMed Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E (2005) Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide. Diabetes Care 28:1132–1138CrossRefPubMed
16.
Zurück zum Zitat American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S629CrossRefPubMedCentral American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S629CrossRefPubMedCentral
17.
Zurück zum Zitat Crowther PS, Cox RJ (2005) A method for optimal division of data sets for use in neural networks. In: Khosla R, Howlett RJ, Jain LC (eds) Knowledge-based intelligent information and engineering systems. KES 2005. Lecture notes in computer science, vol. 3684, Springer, Berlin, Heidelberg, pp 1–7 Crowther PS, Cox RJ (2005) A method for optimal division of data sets for use in neural networks. In: Khosla R, Howlett RJ, Jain LC (eds) Knowledge-based intelligent information and engineering systems. KES 2005. Lecture notes in computer science, vol. 3684, Springer, Berlin, Heidelberg, pp 1–7
18.
Zurück zum Zitat Hocking RR (1976) The analysis and selection of variables in linear regression. Biometrics 32:1–49CrossRef Hocking RR (1976) The analysis and selection of variables in linear regression. Biometrics 32:1–49CrossRef
19.
Zurück zum Zitat Robinson AP, Froese RE (2004) Model validation using equivalence tests. Ecol Model 176:349–358CrossRef Robinson AP, Froese RE (2004) Model validation using equivalence tests. Ecol Model 176:349–358CrossRef
20.
Zurück zum Zitat Michiels S, Le Maitre A, Buyse M et al (2009) Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncol 10:341–350CrossRefPubMed Michiels S, Le Maitre A, Buyse M et al (2009) Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncol 10:341–350CrossRefPubMed
21.
Zurück zum Zitat Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35:1605–1610CrossRefPubMedPubMedCentral Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35:1605–1610CrossRefPubMedPubMedCentral
Metadaten
Titel
Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index
verfasst von
Andrea Tura
Gaetano Chemello
Julia Szendroedi
Christian Göbl
Kristine Færch
Jana Vrbíková
Giovanni Pacini
Ele Ferrannini
Michael Roden
Publikationsdatum
26.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 5/2018
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4568-4

Weitere Artikel der Ausgabe 5/2018

Diabetologia 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.